Optimising NHS patient pathways in renal care
Sue Thomas explains how Wilmington Healthcare’s unique behavioural methodology is helping to define best practice pathways for patients with chronic kidney disease (CKD) during the pandemic
Read More
Search Results for: Sue Thomas
Exposing the true cost of care
Sue Thomas and Paul Midgley of Wilmington Healthcare explore how the proposed national patient data sharing scheme would change the NHS
Read More
Lilly’s Lartruvo bags US nod for soft tissue sarcoma
Eli Lilly’s Lartruvo has been approved by the US Food and Drug Administration to treat soft tissue sarcoma.
Read More
How can pharma help the NHS harness the power of data?
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
Read More
The new power brokers
How pharma should adapt to changes in the NHS that are impacting decision-making in primary care
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
